Evidence map›Paper›PMID 42318019›Full record

ArticleFrontiers in cellular and infection microbiology2026

Antimicrobial resistance characteristics and associated molecular mechanisms of clinically isolated

Qiong Huang, Rong Xiang, Yong Wu, Wenfeng Zhang, Wei Xie, Zhiyong Liu, Nian Quan, Yuan Gao, Zhongzheng Xiong, Li He and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Qiong Huang *Department of Laboratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Rong Xiang *Precision Medicine Center, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yong Wu *Department of Laboratory Medicine, Fengdu General Hospital, Chongqing, China.
Wenfeng ZhangDepartment of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Wei XieDepartment of Laboratory Medicine, Children's Hospital of Chongqing Medical University, Chongqing, China.
Zhiyong LiuDepartment of Laboratory Medicine, The First Affiliated Hospital of Army Medical University, Chongqing, China.
Nian QuanDepartment of Laboratory Medicine, The Second Affiliated Hospital of Army Medical University, Chongqing, China.
Yuan GaoDepartment of Laboratory Medicine, Chongqing University Jiangjin Hospital, School of Medicine, Chongqing University, Chongqing, China.
Zhongzheng XiongDepartment of Laboratory Medicine, Dianjiang People's Hospital of Chongqing, Chongqing, China.
Li HeDepartment of Laboratory Medicine, People's Hospital of Shizhu Tujia Autonomous County, Chongqing, China.
Jing FuDepartment of Laboratory Medicine, Zhongxian People's Hospital of Chongqing, Chongqing, China.
Di MuDepartment of Laboratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Yunying WangDepartment of Laboratory Medicine, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Global systematic research on Results: Ampicillin had the highest resistance rate (76.2%), followed by azithromycin (38.2%) and amoxicillin/clavulanic acid (23.8%); tetracycline (6.2%) and levofloxacin (0.6%) had low resistance rates. No resistance to ceftazidime, cefotaxime, or meropenem was detected. The β-lactamase positive rate was 67.2%. The Conclusion: Chongqing

Indexed as

Anti-Bacterial AgentsDrug Resistance, BacterialDrug Resistance, Multiple, BacterialHaemophilus InfectionsHaemophilus influenzaeAmpicillinBacterial Proteinsbeta-LactamasesChinaHumansMicrobial Sensitivity TestsThird Generation CephalosporinsAmpicillinAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesThird Generation Cephalosporinsantibiotic resistanceBLNARHaemophilus influenzaemulti-center surveillanceresistance mechanismswhole-genome sequencing

Identifiers

PMID42318019
PMCPMC13272400

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.